AORTARTIVION, INC.vs its industry peers
A metric-by-metric comparison of ARTIVION, INC. against Surgical & Medical Instruments & Apparatus — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Empresa | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| AORTEsta | $1.2B#8 | — | 2.6x#6 | 2.6x#7 | 13.6%#9 | 173.1%#1 | 7.6%#3 | 2.2%#4 | 3.0%#2 | 5#4 | -48.1%#13 | 0.3%#2 |
| INSP | $1.8B#1 | 18.4x#1 | 2.2x#3 | 2.0x#5 | 13.6%#8 | 171.8%#2 | 5.6%#4 | 17.6%#2 | 7.7%#1 | 7#1 | -16.5%#10 | — |
| KMTS | $1.8B#2 | — | 7.9x#11 | 18.5x#15 | 59.0%#1 | -15.6%#12 | -141.6%#15 | -59.2%#13 | -59.5%#9 | 4#7 | 12.4%#7 | — |
| NVCR | $1.6B#3 | — | 4.5x#8 | 2.4x#6 | 8.3%#11 | 19.4%#6 | -23.5%#10 | -38.9%#11 | -32.5%#7 | 3#9 | 10.0%#8 | — |
| SKIN | $1.3B#4 | — | 23.5x#15 | 4.3x#10 | -10.0%#15 | 67.4%#3 | -6.9%#5 | -17.1%#8 | — | — | -63.1%#15 | — |
| TNDM | $1.2B#5 | — | 9.5x#12 | 1.2x#2 | 7.9%#12 | -113.2%#15 | -18.5%#9 | -157.0%#15 | -26.3%#6 | 3#9 | 24.3%#5 | — |
| ATEC | $1.2B#6 | — | — | 1.5x#3 | 25.0%#4 | 11.6%#9 | -10.7%#6 | — | -17.7%#5 | 6#2 | -60.8%#14 | — |
| SGP | $1.2B#7 | — | 5.0x#9 | — | — | -36.7%#14 | — | -17.2%#9 | — | — | — | — |
| PRCT | $1.2B#9 | — | 3.4x#7 | 3.7x#9 | 37.2%#3 | -4.5%#10 | -33.7%#12 | -0.0%#5 | -63.4%#10 | 2#11 | -41.6%#11 | — |
| SIBN | $1.1B#10 | — | 5.8x#10 | 5.3x#11 | 20.2%#5 | 38.8%#4 | -11.1%#7 | -10.2%#6 | -12.0%#4 | 5#4 | 58.0%#4 | — |
| IART | $1.1B#11 | 80.1x#4 | 1.0x#1 | 0.6x#1 | 1.5%#13 | -7389.9%#16 | -30.2%#11 | -48.5%#12 | -32.6%#8 | 6#2 | 18.6%#6 | — |
| IRMD | $1.0B#12 | 43.0x#3 | 9.7x#13 | 12.3x#14 | 14.4%#7 | 16.9%#7 | 31.2%#1 | 21.1%#1 | — | — | -3.0%#9 | 1.5%#1 |
| BBNX | $826M#13 | — | 2.1x#2 | 8.2x#13 | 53.9%#2 | -33.7%#13 | -71.5%#14 | -18.2%#10 | — | — | -45.2%#12 | — |
| KIDS | $823M#14 | — | 2.4x#4 | 3.5x#8 | 15.4%#6 | -4.8%#11 | -16.6%#8 | -11.7%#7 | -8.7%#3 | 4#7 | 92.1%#1 | — |
| TCMD | $566M#15 | 24.5x#2 | 2.5x#5 | 1.7x#4 | 12.5%#10 | 12.5%#8 | 8.9%#2 | 8.4%#3 | — | — | 60.3%#3 | — |
| SGHT | $525M#16 | — | 9.9x#14 | 6.8x#12 | -3.1%#14 | 25.4%#5 | -48.0%#13 | -72.6%#14 | -266.6%#11 | 5#4 | 86.9%#2 | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 3841). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Table built 2026-11-04.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice